STAPHYLOCOCCUS SP - ANVISA Registration 81062710017

Access comprehensive regulatory information for STAPHYLOCOCCUS SP in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81062710017 and manufactured by manufacturer not specified. The registration is held by Cepheid Brasil Importação, Exportação e Comércio de Produtos de Diagnósticos ltda with validity until Sep 19, 2026.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including CEPHEID, ROCHE MOLECULAR SYSTEMS, INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81062710017
2 Related Devices
Registration Details
ANVISA Registration Number: 81062710017
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Xpert MRSA
Risk Class III

Registration Details

81062710017

25351817229201638

18628083000123

Dates and Status

Sep 19, 2016

19/09/2026

09/18/2025 19:00:01

Xpert MRSA
Risk Class III

Registration Details

81062710017

25351817229201638

18628083000123

Company Information

CEPHEID
United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Sep 19, 2016

19/09/2026

09/18/2025 19:00:01